Dr. Pierre R. Brondeau is the Lead Independent Director of the TE Board of Directors. He has served on the TE Connectivity Board since its inception in June 2007. Dr. Brondeau has been President and Chief Executive Officer of FMC Corporation since January 2010 and serves as Chairman of its Board of Directors. FMC Corporation is a diversified global chemical company serving agricultural, industrial and consumer markets. Prior to joining FMC Corporation, he was President and Chief Executive Officer of Dow Advanced Materials, a manufacturer of specialty materials and a wholly‑owned subsidiary of the Dow Chemical Company, upon the April 2009 merger of Rohm & Haas Company and Dow Chemical Company, until September 2009. From 2008 to 2009, Dr. Brondeau served as President and Chief Operating Officer of Rohm & Haas Company and from 2006 to 2008, as Executive Vice President of electronics materials and specialty materials of Rohm & Haas Company. Dr. Brondeau joined Rohm & Haas in 1989 as European Marketing Manager for the Plastics Additives business unit located in Paris. In 1991, he transferred to Valbonne, France, to head the Technical Service and Development Laboratories. Dr. Brondeau was promoted to Director of Plastics Additives Research in 1993, and moved to Shipley Company, which was later renamed Rohm & Haas Electronic Materials, as Director, Research, Sales & Marketing in 1995. He held top leadership positions at Shipley Company, including Vice President, Operations and Technology, President, Chief Operating Officer and Chief Executive Officer from 1997. From 2003, Dr. Brondeau served in several executive capacities in the Electronic Materials and Specialty Materials business. In May 2008, he was elected President & Chief Operating Officer of Rohm & Haas Company. Earlier in his career, he worked at Air Liquide in France. He is the Chairman of the American Chemistry Council. Dr. Brondeau has a Bachelor’s degree in Biochemical Engineering from INSA France; a Master’s degree in Biochemical Engineering from the University of Montpellier, France; and a Ph.D. in Biochemical Engineering from INSA France.

 Manufacturing Medical Devices